These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11023820)

  • 1. Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition.
    Leuthäuser K; Gujer R; Aldecoa A; McKinney RA; Muff R; Fischer JA; Born W
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):347-51. PubMed ID: 11023820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
    Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
    Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
    Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
    Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
    Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
    Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding and activation of the CGRP receptor.
    Conner AC; Simms J; Barwell J; Wheatley M; Poyner DR
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):729-32. PubMed ID: 17635135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
    Aldecoa A; Gujer R; Fischer JA; Born W
    FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor pharmacology.
    Young A
    Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH
    J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
    Yallampalli C; Kondapaka SB; Lanlua P; Wimalawansa SJ; Gangula PR
    Biol Reprod; 2004 Apr; 70(4):1055-62. PubMed ID: 14668209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
    Ittner LM; Koller D; Muff R; Fischer JA; Born W
    Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
    Steiner S; Muff R; Gujer R; Fischer JA; Born W
    Biochemistry; 2002 Sep; 41(38):11398-404. PubMed ID: 12234182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.
    Kuwasako K; Cao YN; Nagoshi Y; Tsuruda T; Kitamura K; Eto T
    Mol Pharmacol; 2004 Jan; 65(1):207-13. PubMed ID: 14722252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    Chatterjee TK; Moy JA; Cai JJ; Lee HC; Fisher RA
    Mol Pharmacol; 1993 Feb; 43(2):167-75. PubMed ID: 8381507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
    Héroux M; Breton B; Hogue M; Bouvier M
    Biochemistry; 2007 Jun; 46(23):7022-33. PubMed ID: 17503773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of constitutive G protein-coupled receptor activity for drug discovery.
    Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
    Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.